Litcius/Paper detail

Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor–induced bullous pemphigoid

Jordan T. Said, Jordan Talia, Erin X. Wei, Arash Mostaghimi, Yevgeniy R. Semenov, Anita Giobbie‐Hurder, Steven T. Chen, Nicole R. LeBoeuf

2022Journal of the American Academy of Dermatology15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBullous pemphigoidDermatologyDiscontinuationCancerPemphigoidRetrospective cohort studyPembrolizumabInternal medicineAdverse effectOncologyAntibodyImmunotherapyImmunologyAutoimmune Bullous Skin DiseasesCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways
Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor–induced bullous pemphigoid | Litcius